Actos Bladder Cancer Lawsuits Could Top 100,000
Actos, the diabetes drug, has been known to increase the risk of bladder cancer for over a decade. But two FDA Actos bladder cancer warning announcements within a year, many have wondered if Actos is the next Avandia. Avandia was also the most prescribed diabetes drug in the United States. It was also described in Newsweek magazine as the poster child for what’s wrong with the FDA. Ultimately, after US senate Finance committee hearings, the FDA stated that Avandia was known to cause more than 83,000 heart attacks. Actos became the leading diabetes drug after the decline of Avandia due to its heart attack, stroke and other cardiovascular problems and the thousands of lawsuits filed over it. Many of the people using Avandia were switched over to Actos, making it the number one diabetes drug in America. The FDA calculation of 83,000 heart attaches caused by Avandia was years before it was pulled from the market. With an ever-increasing percentage of the population having Type 2 diabetes, along with Avandia’s absence from the market, even more people may have been exposed to Actos bladder cancer risks. This has caused many to speculate that the number of Actos bladder cancer lawsuits will top the number of Avandia lawsuits. Here’s the real kicker, Actos was shown to have an increase in bladder cancer in its very first tests, the ones performed on laboratory rats and mice. But with Avandia’s linkage to cardiovascular disease, that was the primary focus of Actos clinical trials after the drug was approved. Lawyers are already lining up to offer free Actos bladder cancer lawsuit case reviews and there may be thousands of plaintiffs already represented by attorneys but not yet having filed their Actos bladder cancer lawsuit. Find more information by clicking here.